These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26016944)

  • 1. Effects of plyometric exercise session on markers of bone turnover in boys and young men.
    Kish K; Mezil Y; Ward WE; Klentrou P; Falk B
    Eur J Appl Physiol; 2015 Oct; 115(10):2115-24. PubMed ID: 26016944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of Bone Turnover Markers and Cytokines to High-Intensity Low-Impact Exercise.
    Mezil YA; Allison D; Kish K; Ditor D; Ward WE; Tsiani E; Klentrou P
    Med Sci Sports Exerc; 2015 Jul; 47(7):1495-502. PubMed ID: 25373482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt Signaling-Related Osteokines at Rest and Following Plyometric Exercise in Prepubertal and Early Pubertal Boys and Girls.
    Klentrou P; Angrish K; Awadia N; Kurgan N; Kouvelioti R; Falk B
    Pediatr Exerc Sci; 2018 Nov; 30(4):457-465. PubMed ID: 29683771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
    Doumouchtsis K; Perrea D; Doumouchtsis S; Tziamalis M; Poulakou M; Vlachos I; Kostakis A
    Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of RANKL and OPG Levels with Bone Resorption in Patients with Acromegaly and Prolactinoma.
    Ozer FF; Dagdelen S; Erbas T
    Horm Metab Res; 2018 Jul; 50(7):562-567. PubMed ID: 29895074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt Signaling-Related Osteokines and Transforming Growth Factors Before and After a Single Bout of Plyometric Exercise in Child and Adolescent Females.
    Dekker J; Nelson K; Kurgan N; Falk B; Josse A; Klentrou P
    Pediatr Exerc Sci; 2017 Nov; 29(4):504-512. PubMed ID: 28530511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential sclerostin and parathyroid hormone response to exercise in boys and men.
    Falk B; Haddad F; Klentrou P; Ward W; Kish K; Mezil Y; Radom-Aizik S
    Osteoporos Int; 2016 Mar; 27(3):1245-1249. PubMed ID: 26361948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute response of plasma markers of bone turnover to a single bout of resistance training or plyometrics.
    Rogers RS; Dawson AW; Wang Z; Thyfault JP; Hinton PS
    J Appl Physiol (1985); 2011 Nov; 111(5):1353-60. PubMed ID: 21868687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in circulating osteoimmune factors may be responsible for high bone resorption rate in HIV-infected children and adolescents.
    Mora S; Zamproni I; Cafarelli L; Giacomet V; Erba P; Zuccotti G; Viganò A
    AIDS; 2007 May; 21(9):1129-35. PubMed ID: 17502723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
    Avbersek-Luznik I; Balon BP; Rus I; Marc J
    Nephrol Dial Transplant; 2005 Mar; 20(3):566-70. PubMed ID: 15665031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women.
    D'Amore M; Fanelli M; D'Amore S; Fontana A; Minenna G
    Panminerva Med; 2006 Dec; 48(4):215-21. PubMed ID: 17215793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
    Alvarez L; Peris P; Guañabens N; Vidal S; Ros I; Pons F; Filella X; Monegal A; Muñoz-Gomez J; Ballesta AM
    Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis.
    Ambroszkiewicz J; Sands D; Gajewska J; Chelchowska M; Laskowska-Klita T
    Adv Med Sci; 2013; 58(2):338-43. PubMed ID: 24277958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in circulating osteoprotegerin and soluble RANKL during diurnal and menstrual cycles in young women.
    Shimizu M; Onoe Y; Mikumo M; Miyabara Y; Kuroda T; Yoshikata R; Ishitani K; Okano H; Ohta H
    Horm Res; 2009; 71(5):285-9. PubMed ID: 19339793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
    Elwakkad AS; El Elshamy KA; Sibaii H
    Epilepsy Res; 2008 Jul; 80(1):47-56. PubMed ID: 18455911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
    Martini G; Gennari L; Merlotti D; Salvadori S; Franci MB; Campagna S; Avanzati A; De Paola V; Valleggi F; Nuti R
    Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does idiopathic hypercalciuria affect bone metabolism during childhood? A prospective case-control study.
    Pavlou M; Giapros V; Challa A; Chaliasos N; Siomou E
    Pediatr Nephrol; 2018 Dec; 33(12):2321-2328. PubMed ID: 30043116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between maternal novel adipocytokines and bone biomarkers in complicated by gestational hypertensive disorders and normal pregnancies.
    Briana DD; Boutsikou M; Boutsikou T; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2013 Aug; 26(12):1219-22. PubMed ID: 23406471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
    Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
    Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis.
    Reyes-García R; Muñoz-Torres M; García DF; Mezquita-Raya P; García Salcedo JA; de Dios Luna J
    Menopause; 2010; 17(1):140-4. PubMed ID: 19574937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.